FIMPsy – Fragebogen zur Inanspruchnahme medizinischer und nicht medizinischer Versorgungsleistungen bei psychischen Erkrankungen: Entwicklung und Verwendung

Grupp, Helen; König, Hans‐Helmut; Riedel‐Heller, Steffi G.; Konnopka, Alexander

doi:10.1055/s-0042-118033

Cited by 24 publications

(15 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…data collection, management and analysis Data will be collected before intervention (t0) after 6 (t6) and 12 months (t12) (see figure 2 for the Consolidated Standards of Reporting Trials flow diagram). The following instruments are used: Diagnostic and Statistical Manual of Mental disorders -Fifth Edition (DSM-V), structured clinical interview (SCID I and II), 42 psychiatric use of care services (FIMPsy questionnaire), 43 general use of health services (FIMA questionnaire), 44 disease remission or responses (HEALTH-49) 45 ; ClinicalGlobal Impressions. 46 Moreover, the use of additional, study specific health services like the use of digital therapy is assessed in a questionnaire.…”

Section: Assignment Of Interventionsmentioning

confidence: 99%

Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER)

et al. 2020

Self Cite

View full text Add to dashboard Cite

IntroductionHealthcare systems around the world are looking for solutions to the growing problem of mental disorders. RECOVER is the synonym for an evidence-based, stepped and cross-sectoral coordinated care service model for mental disorders. RECOVER implements a cross-sectoral network with managed care, comprehensive psychological, somatic and social diagnostics, crisis resolution and a general structure of four severity levels, each with assigned evidence-based therapy models (eg, assertive community treatment) and therapies (eg, psychotherapy). The study rationale is the investigation of the effectiveness and efficiency of stepped and integrated care in comparison to standard care.Methods and analysisThe trial is conducted in accordance to the Standard Protocol Items: Recommendations for Interventional Trials Statement. The study aims to compare the RECOVER model with treatment as usual (TAU). The following questions are examined: Does RECOVER reduce healthcare costs compared with TAU? Does RECOVER improve patient-relevant outcomes? Is RECOVER cost-effective compared with TAU? A total sample of 890 patients with mental disorders will be assessed at baseline and individually randomised into RECOVER or TAU. Follow-up assessments are conducted after 6 and 12 months. As primary outcomes, cost reduction, improvement in symptoms, daily functioning and quality of life as well as cost-effectiveness ratios will be measured. In addition, several secondary outcomes will be assessed. Primary and secondary outcomes are evaluated according to the intention-to-treat principle. Mixed linear or logistic regression models are used with the direct maximum likelihood estimation procedure which results in unbiassed estimators under the missing-at-random assumption. Costs due to healthcare utilisation and productivity losses are evaluated using difference-in-difference regressions.Ethics and disseminationEthical approval from the ethics committee of the Hamburg Medical Association has been obtained (PV5672). The results will be disseminated to service users and their families via the media, to healthcare professionals via professional training and meetings and to researchers via conferences and publications.Trial registration number and registry nameClinicalTrials.gov (NCT03459664), RECOVERProtocol version19 March 2020 (V.3.0)

show abstract

Section: Assignment Of Interventionsmentioning

confidence: 99%

Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER)

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…The analyses will consider direct costs (resource utilization) and indirect costs (productivity losses). The assessment of resource utilization and productivity losses is based on the “Client Sociodemographic and Service Receipt Inventory” (CSSRI) [ 49 – 52 ]. We additionally assess in more detail health care use of patients randomized to the TAU-O group.…”

Section: Methodsmentioning

confidence: 99%

Specialized post-inpatient psychotherapy for sustained recovery in anorexia nervosa via videoconference – study protocol of the randomized controlled SUSTAIN trial

et al. 2021

View full text Add to dashboard Cite

Background A major barrier to long-term recovery from anorexia nervosa (AN) are early and frequent relapses after inpatient treatment. There is an urgent need for enhanced continuity of specialized care involving effective aftercare interventions and relapse prevention strategies in order to improve the long-term outcome for patients with AN. Methods SUSTAIN is a multi-center, prospective, randomized-controlled trial investigating the efficacy of a novel post-inpatient aftercare intervention for patients with AN as compared to optimized treatment-as-usual (TAU-O). The SUSTAIN aftercare intervention is based on the cognitive-interpersonal maintenance model of AN and specifically tailored to achieve sustained recovery in AN following inpatient treatment. The SUSTAIN aftercare intervention comprises 20 treatment sessions over eight months and will be predominantly delivered via videoconference to overcome discontinuity of care. TAU-O refers to routine outpatient psychotherapy as generally offered in the German health care system. A total number of 190 patients receiving inpatient or day-hospital treatment for AN will be randomized and assessed over a 14-month period following randomization including a 6 months follow-up. Minimum Body Mass Index (BMI) is 15 kg/m2 at trial inclusion. The primary efficacy endpoint is the change in BMI between baseline (T0) and end of treatment (T2) adjusted for baseline BMI. Key secondary outcomes comprise eating disorder and general psychopathology, quality of life, proportion of relapse and of weight restoration, and cost-effectiveness. Discussion The results of the present trial will provide evidence if the novel aftercare intervention fosters sustained recovery in patients affected by severe courses of AN. Trial registration The SUSTAIN trial was prospectively registered on November 18, 2020, under the registration number DRKS00023372 at the German Clinical Trials Register (https://www.drks.de/drks_web/) which is an acknowledged primary register of the World Health Organization (http://apps.who.int/trialsearch/). Protocol version: 1.2.

show abstract

“…Secondary outcomes include differences of the absolute change in mean depressive and anxiety symptom severity on the PHQ-ADS at 12 months between both study arms. At 6 and 12 months after baseline assessment, we will also calculate the absolute change in mean depressive and anxiety symptom severity on the PHQ-9 and GAD-7, respectively along with differences in mean burden of speci c somatic complaints (Somatic Symptom Disorder-B Criteria Scale, SSD-12 [66]), recovery (Recovery Assessment Scale, RAS-G [44]), health-related quality of life (SF-12 questionnaire [67], and EQ-5D 5L [68]), quality and patient-centredness of chronic illness care (Patient Assessment of Chronic Illness Care-Short Form, PACIC-Short Form [69]), adverse effects (Inventory for the Assessment of Negative Effects of Psychotherapy, INEP [70]), and health service use (Questionnaire for the Assessment of Medical and non-Medical Resource Utilisation in Mental Disorders, FIMPsy [71]) between both study arms. The cost-effectiveness of the primary care embedded MHSVC model of care compared to usual care over the study period will comprise additional secondary outcomes.…”

Section: Secondary Outcomesmentioning

confidence: 99%

“…Health service use will be measured using the FIMPsy questionnaire which is particularly suited for patients with mental disorders [71,76]. It assesses the following services in the preceding six months retrospectively: psychiatric counselling, assisted living, and occupational integration.…”

Section: Secondary Outcomesmentioning

confidence: 99%

“…MHS salaries) are taken from the study documentation. Costs regarding inpatient and outpatient health care use, psychiatric counselling, assisted living, occupational integration, absent days, and antipsychotic medication are assessed at baseline, six and 12 months after baseline referring to either the last six month by a standardised instrument [71]. This questionnaire was also used in the feasibility trial (PROVIDE-B) [44] and deemed to be applicable in the e ciency trial to assess resource use.…”

Section: Cost-effectiveness and Cost-utility Analysismentioning

confidence: 99%

See 1 more Smart Citation

Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial)

Haun

Tönnies

Brinster

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: The majority of people with mental disorders, including those with severe and chronic disorders, are treated solely by their general practitioner (GP). Nevertheless, specialised mental health care may be required for specific patients. Notably, the accessibility of mental health specialist care is mainly complicated by (a) long waiting times for an appointment with specialists, (b) long travel distances to specialists, particularly in rural and remote areas and (c) patients’ reservations about mental health specialist care (including fear of being stigmatised by seeking such care). To mitigate those barriers, technology-based integrated care models have been proposed. The purpose of this study is to examine the effectiveness and cost-effectiveness of a mental health specialist video consultations model versus treatment as usual in patients with depression or anxiety disorders in primary care. Methods: In an individually randomised, prospective, two-arm superiority trial with parallel group design, N = 320 patients with anxiety and/or depressive disorder will be recruited in general practices. The intervention includes a newly developed treatment model based on video consultations with focus on diagnostics, treatment planning, and short-term intervention by mental health specialists. We will systematically compare the effectiveness, cost-effectiveness, and adverse effects of this new model with usual care by the GP: The primary outcome is the absolute change in the mean depressive and anxiety symptom severity measured on the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) from baseline to 6 months after baseline assessment. Follow-up in both groups will be conducted by blinded outcome assessors at 6 months and 12 months after baseline. The main analysis will be based on the intention-to-treat principle. We will optimise the likelihood of treatment effectiveness by strict inclusion criteria for patients, enhanced intervention integrity, and conducting a process evaluation. Discussion: To the best of our knowledge, this is the first confirmatory study on a video-based, integrated care model for the treatment of anxiety and depressive disorders in GP patients in Germany. Trial registration: ClinicalTrials.gov, United States National Institutes of Health (NCT04316572, https://clinicaltrials.gov/ct2/show/NCT04316572). Prospectively registered on 20 March 2020.

show abstract

FIMPsy – Fragebogen zur Inanspruchnahme medizinischer und nicht medizinischer Versorgungsleistungen bei psychischen Erkrankungen: Entwicklung und Verwendung

Abstract: FIMPsy covers many services for patients with mental disorders. It can be applied in economic evaluations and thus facilitate and standardize their implementation.

Cited by 24 publications

References 30 publications

Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER)

Study protocol for a randomised controlled trial evaluating an evidence-based, stepped and coordinated care service model for mental disorders (RECOVER)

Specialized post-inpatient psychotherapy for sustained recovery in anorexia nervosa via videoconference – study protocol of the randomized controlled SUSTAIN trial

Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial)

Contact Info

Product

Resources

About